Defining the mode of action of cisplatin combined with NUC-1031, a phosphoramidate modification of gemcitabine von Patel, Dillum, Dickson, Alison L., Zickuhr, Greice M., Um, In Hwa, Read, Oliver J., Czekster, Clarissa M., Mullen, Peter, Harrison, David J., Bré, Jennifer

Volltext

DESI-MSI-guided exploration of metabolic-phenotypic relationships reveals a correlation between PI 38:3 and proliferating cells in clear cell renal cell carcinoma via single-sectio... von Zickuhr, Greice M., Um, In Hwa, Laird, Alexander, Harrison, David J., Dickson, Alison L.

Volltext

Human 2′-Deoxynucleoside 5′-Phosphate N‑Hydrolase 1: Mechanism of 2′-Deoxyuridine 5′-Monophosphate Hydrolysis von Devi, Suneeta, Carberry, Anna E., Zickuhr, Greice M., Dickson, Alison L., Harrison, David J., da Silva, Rafael G.

Volltext

The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent von Bré, Jennifer, Dickson, Alison L., Read, Oliver J., Zhang, Ying, McKissock, Fiona G., Mullen, Peter, Tang, Peijun, Zickuhr, Greice M., Czekster, Clarissa M., Harrison, David J.

Volltext